Wordt geladen...
Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma
AIM: To assess the efficacy and safety of weekly docetaxel plus a fixed-dose rate (FDR) of gemcitabine in metastatic esophageal squamous cell carcinoma (SCC). METHODS: A multi-center, open-label, prospective phase II study was designed. Thirty-three esophageal SCC patients with documented progressio...
Bewaard in:
| Gepubliceerd in: | World J Gastroenterol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Baishideng Publishing Group Inc
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4394089/ https://ncbi.nlm.nih.gov/pubmed/25892878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i14.4268 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|